Search Results

You are looking at 81 - 90 of 108 items for :

  • "Bladder cancer" x
  • Refine by Access: Content accessible to Me x
Clear All
Full access

Michelle C. Nguyen, Manisha H. Shah, David A. Liebner, Floor J. Backes, John Phay, and Lawrence A. Shirley

–small cell lung cancer, classical Hodgkin lymphoma, gastric cancer, head and neck squamous cell cancer, urothelial bladder cancer, and microsatellite-unstable tumors. Multiple clinical trials are currently underway to evaluate its effectiveness in other solid

Full access

Robert J. Motzer, Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Sam S. Chang, Toni K. Choueiri, Ithaar H. Derweesh, Shilpa Gupta, Steven L. Hancock, Jenny J. Kim, Timothy M. Kuzel, Elaine T. Lam, Clayton Lau, Ellis G. Levine, Daniel W. Lin, Kim A. Margolin, M. Dror Michaelson, Thomas Olencki, Roberto Pili, Elizabeth R. Plimack, Edward N. Rampersaud, Bruce G. Redman, Charles J. Ryan, Joel Sheinfeld, Kanishka Sircar, Brad Somer, Jue Wang, Richard B. Wilder, Mary A. Dwyer, and Rashmi Kumar

- 50 Chemotherapy regimens used in the treatment of bladder cancer have been reported to achieve responses in collecting duct carcinoma. In a multicenter prospective study, 23 patients with no prior therapy were treated with a combination of

Full access

Lainie Martin and Russell J. Schilder

Kraemer K . Vascular endothelial growth factor antisense pretreatment of bladder cancer cells significantly enhances the cytotoxicity of mitomycin C, gemcitabine and cisplatin . J Urol 2005 ; 174 : 328 – 331 . 12. Sanborn RE Sandler AB

Full access

Alexander P. Cole, Chang Lu, Marieke J. Krimphove, Julie Szymaniak, Maxine Sun, Sean A. Fletcher, Stuart R. Lipsitz, Brandon A. Mahal, Paul L. Nguyen, Toni K. Choueiri, Adam S. Kibel, Adil H. Haider, and Quoc-Dien Trinh

, . Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival? Cancer 2019 ; 125 : 1319 – 1329 . 10.1002/cncr.31926 30633323 18. Krimphove MJ , Cole AP , Fletcher SA

Full access

Arti Hurria, Ilene S. Browner, Harvey Jay Cohen, Crystal S. Denlinger, Mollie deShazo, Martine Extermann, Apar Kishor P. Ganti, Jimmie C. Holland, Holly M. Holmes, Mohana B. Karlekar, Nancy L. Keating, June McKoy, Bruno C. Medeiros, Ewa Mrozek, Tracey O’Connor, Stephen H. Petersdorf, Hope S. Rugo, Rebecca A. Silliman, William P. Tew, Louise C. Walter, Alva B. Weir III, and Tanya Wildes

Guidelines for AML in centers skilled in the management and supportive care of AML (to view the most recent version of these guidelines, visit the NCCN Web site at www.NCCN.org ). Bladder Cancer: Intravesical immunotherapy with Bacillus Calmette

Full access

Michael Xiang and Elizabeth A. Kidd

, Shipley WU , . Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233 . J

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Don Dizon, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, Muhammad Raza, M. Alma Rodriguez, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass

. Wyszynski A Tanyos SA Rees JR . Body mass and smoking are modifiable risk factors for recurrent bladder cancer . Cancer 2014 ; 120 : 408 – 414 . 7. Hudis CA Jones L . Promoting exercise after a cancer diagnosis: easier said than done . Br J

Full access

Vivek Verma, Pamela K. Allen, Charles B. Simone II, Hiram A. Gay, and Steven H. Lin

in glioblastoma . J Neurooncol 2017 ; 135 : 173 – 181 . 35. Haque W Verma V Butler EB Teh BS . Radical cystectomy versus chemoradiation for musle-invasive bladder cancer: impact of treatment facility and sociodemographics . Anticancer

Full access

Vivek Verma, Amy C. Moreno, Waqar Haque, Penny Fang, and Steven H. Lin

: 146 – 154 . 24. Haque W Verma V Butler EB Teh BS . Radical cystectomy versus chemoradiation for muscle-invasive bladder cancer: impact of treatment facility and sociodemographics . Anticancer Res 2017 ; 37 : 5603 – 5608 . 25

Full access

Christopher M. Booth, Sulaiman Nanji, Xuejiao Wei, Yingwei Peng, James J. Biagi, Timothy P. Hanna, Monika K. Krzyzanowska, and William J. Mackillop

-invasive bladder cancer: a population-based outcomes study . Cancer 2014 ; 120 : 1630 – 1638 . 11. Meyer RM . Generalizing the results of cancer clinical trials . J Clin Oncol 2010 ; 28 : 187 – 189 . 12. Booth CM Mackillop WJ